Emerging Medication in Australia: A Potential Breakthrough for Obesity Management ?
Australia is eagerly anticipating the arrival of retatrutide, a innovative dual GIP and GLP-1 receptor therapy, representing a potential advance in obesity treatment . Early study data have demonstrated impressive results, showing greater efficacy than existing treatments like semaglutide. While